Concepedia

Michael M. Allevato

MM

8

Publications

622

Citations

8

H-Index

2017

Active since

Affiliations

University of California San Diego(Current)

Celldex Therapeutics (United States)

National Institute of Dental and Craniofacial Research

University of California, Riverside

Sichuan University

Michael M. Allevato is an author at University of California San Diego specializing in medicine, gene expression, and natural sciences.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

Zhiyong Wang, Victoria H. Wu, Michael M. Allevato et al. · Nature Communications · 2019 · 166 citations · Full text

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji et al. · Nature Communications · 2022 · 152 citations · Full text

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer

Zhiyong Wang, Yusuke Goto, Michael M. Allevato et al. · Nature Communications · 2021 · 83 citations · Full text

, , +11

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

Zhiyong Wang, Xiaodong Feng, Alfredo Molinolo et al. · Cancer Research · 2019 · 81 citations · Full text

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs

Michael M. Allevato, Eugene Bolotin, Mark H. Grossman et al. · PLoS ONE · 2017 · 60 citations · Full text

, , +18

Rows per page

1–5 of 8